BREAKING
REFI Posts $0.43 Q4 Adjusted EPS as Revenue Surges 15.6% Year-Over-Year 3 minutes ago MOS Stock Surges 10% on Rare Earth Diversification Strategy Beyond Fertilizers 4 minutes ago Precision BioSciences (DTIL) Swings to $1.05 EPS in Q4, Reversing $2.22 Year-Ago Loss 20 minutes ago CareCloud (CCLD) Reports EPS of $0.04 for Q4 FY25; Revenue Rises 22% 37 minutes ago Alliance Laundry (ALH) Q4 EPS Beats at $0.24; Guides FY26 Revenue 52 minutes ago Saga Communications (SGA) Reports Adjusted EPS of $1.27; Revenue Declines to $26.5M 1 hour ago Gambling.com (GAMB) Posts $0.30 Adjusted EPS on Record $46.2M Revenue, Up 31% YoY 1 hour ago Li Auto (LI) Earnings Beat by 15.2% Despite Revenue Plunging 90.7% Year-Over-Year 2 hours ago Full Truck Alliance (YMM) Q4 Revenue Plummets 85.6% to $456.5M as EPS Falls 85.9% to $0.14 2 hours ago Highpeak Energy Inc (HPK) Reports Wider Loss Q4 EPS Estimates by 188.1% 2 hours ago REFI Posts $0.43 Q4 Adjusted EPS as Revenue Surges 15.6% Year-Over-Year 3 minutes ago MOS Stock Surges 10% on Rare Earth Diversification Strategy Beyond Fertilizers 4 minutes ago Precision BioSciences (DTIL) Swings to $1.05 EPS in Q4, Reversing $2.22 Year-Ago Loss 20 minutes ago CareCloud (CCLD) Reports EPS of $0.04 for Q4 FY25; Revenue Rises 22% 37 minutes ago Alliance Laundry (ALH) Q4 EPS Beats at $0.24; Guides FY26 Revenue 52 minutes ago Saga Communications (SGA) Reports Adjusted EPS of $1.27; Revenue Declines to $26.5M 1 hour ago Gambling.com (GAMB) Posts $0.30 Adjusted EPS on Record $46.2M Revenue, Up 31% YoY 1 hour ago Li Auto (LI) Earnings Beat by 15.2% Despite Revenue Plunging 90.7% Year-Over-Year 2 hours ago Full Truck Alliance (YMM) Q4 Revenue Plummets 85.6% to $456.5M as EPS Falls 85.9% to $0.14 2 hours ago Highpeak Energy Inc (HPK) Reports Wider Loss Q4 EPS Estimates by 188.1% 2 hours ago
ADVERTISEMENT
Breaking News

Gyre Therapeutics (GYRE) Posts Q4 FY25 Loss of $0.02; misses estimates

Gyre Therapeutics posts $0.05 EPS vs $0.01 estimate on $37.2M revenue, guides fiscal 2026 to $100.5M-$111M.

$GYRE
March 12, 2026 1 min read

Gyre Therapeutics posts $0.05 EPS vs $0.01 estimate on $37.2M revenue, guides fiscal 2026 to $100.5M-$111M.

Loss Per Share (GAAP)
$0.02
Revenue
$37.2M
What to Watch: Track Q1 2026 revenue momentum when the company next reports to validate whether the $100.5 million floor is conservative or aggressive.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

Related: Gyre Therapeutics Inc (GYRE) Beats Q4 EPS Estimates by 368.0% | VRCA: Verrica (VRCA) Q4 Loss Narrows to $0.51/Share as YCANTH Revenue Soars 1,383% YoY | BTMD: Biote (BTMD) Q4 Earnings Plunge 84% YoY to $0.06 Despite Flat Revenue | BTMD: Biote Corp (BTMD) Q4 EPS Plunges 84% to $0.06 Despite Flat Revenue at $49.5M | GRDN: Guardian Pharmacy (GRDN) Q4 EPS Crushes Estimates by 38%, Raises 2026 EBITDA Guidance to $124M | Full GYRE analysis on AlphaStreet

ADVERTISEMENT
Tags: #GYRE

Related Articles